Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Opsens Inc (OPSSF)

Opsens Inc (OPSSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.0600 +3.83%
on 11/16/23
2.1400 -0.05%
on 12/04/23
+0.0759 (+3.68%)
since 11/13/23
3-Month
1.1800 +81.26%
on 09/27/23
2.1400 -0.05%
on 12/04/23
+0.7489 (+53.88%)
since 09/13/23
52-Week
0.9700 +120.51%
on 05/03/23
2.1400 -0.05%
on 12/04/23
+0.7399 (+52.89%)
since 12/13/22

Most Recent Stories

More News
HAEMONETICS COMPLETES ACQUISITION OF OPSENS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 75.44 (-1.90%)
OPS.TO : 2.90 (unch)
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 75.44 (-1.90%)
OPS.TO : 2.90 (unch)
OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 75.44 (-1.90%)
OPS.TO : 2.90 (unch)
OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED

All amounts in this press release are in Canadian dollars. Clearance under both the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the...

OPSSF : 2.1389 (+0.64%)
HAE : 75.44 (-1.90%)
OPS.TO : 2.90 (unch)
OPSENS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS

/CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on...

OPSSF : 2.1389 (+0.64%)
OPS.TO : 2.90 (unch)
INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION

All amounts in this press release are in Canadian dollars. Leading independent proxy advisor says cash offer provides meaningful 50.3% premium to OpSens Inc.'s...

OPSSF : 2.1389 (+0.64%)
HAE : 75.44 (-1.90%)
OPS.TO : 2.90 (unch)
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF) announces that the Québec Superior Court (the "Court") issued an interim order...

OPSSF : 2.1389 (+0.64%)
HAE : 75.44 (-1.90%)
OPS.TO : 2.90 (unch)
OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE

/CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on...

MDT : 81.03 (+1.30%)
OPSSF : 2.1389 (+0.64%)
OPS.TO : 2.90 (unch)
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023

/CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on...

OPSSF : 2.1389 (+0.64%)
OPS.TO : 2.90 (unch)
OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

HAE : 75.44 (-1.90%)
OPSSF : 2.1389 (+0.64%)
OPS.TO : 2.90 (unch)

Key Turning Points

3rd Resistance Point 2.1581
2nd Resistance Point 2.1485
1st Resistance Point 2.1437
Last Price 2.1389
1st Support Level 2.1293
2nd Support Level 2.1197
3rd Support Level 2.1149

See More

52-Week High 2.1400
Last Price 2.1389
Fibonacci 61.8% 1.6931
Fibonacci 50% 1.5550
Fibonacci 38.2% 1.4169
52-Week Low 0.9700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar